Raymond Dwek - Net Worth and Insider Trading

Raymond Dwek Net Worth

The estimated net worth of Raymond Dwek is at least $717,500 dollars as of 2024-11-10. Raymond Dwek is the Director of United Therapeutics Corp and owns about 1,750 shares of United Therapeutics Corp (UTHR) stock worth over $717,500. Details can be seen in Raymond Dwek's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raymond Dwek has not made any transactions after 2024-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Raymond Dwek

To

Raymond Dwek Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond Dwek owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of Raymond Dwek’s form 4 insider trades.

Insider Ownership Summary of Raymond Dwek

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2024-08-02 director

Raymond Dwek Latest Holdings Summary

Raymond Dwek currently owns a total of 1 stock. Raymond Dwek owns 1,750 shares of United Therapeutics Corp (UTHR) as of August 2, 2024, with a value of $717,500.

Latest Holdings of Raymond Dwek

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2024-08-02 1,750 410.00 717,500

Holding Weightings of Raymond Dwek


Raymond Dwek Form 4 Trading Tracker

According to the SEC Form 4 filings, Raymond Dwek has made a total of 4 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in United Therapeutics Corp is the sale of 5,000 shares on August 2, 2024, which brought Raymond Dwek around $2 Million.

Insider Trading History of Raymond Dwek

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raymond Dwek Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Raymond Dwek Ownership Network

Ownership Network List of Raymond Dwek

No Data

Ownership Network Relation of Raymond Dwek

Insider Network Chart

Raymond Dwek Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Raymond Dwek is the director of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , CFO and Treasurer James Edgemond , and director & Chief Executive Officer Martine A Rothblatt .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Raymond Dwek made no insider transaction in United Therapeutics Corp (UTHR). Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 128,500 shares made by Paul A Mahon , and a net sale of 133,718 shares made by James Edgemond .

In summary, during the past 3 months, insiders sold 189,847 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 189,847 shares. During the past 18 months, 1,105,161 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,105,161 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

Raymond Dwek Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond Dwek. Currently GuruFocus does not have mailing address information for Raymond Dwek.